Found: 37
Select item for more details and to access through your institution.
PLANT GROWTH, FLOWERING PHENOLOGIES, AND YIELDS OF CORN, BEANS AND SQUASH GROWN IN PURE STANDS AND MIXTURES IN COSTA RICA.
- Published in:
- Journal of Applied Ecology, 1982, v. 19, n. 3, p. 901, doi. 10.2307/2403292
- By:
- Publication type:
- Article
THE EFFECT OF DROUGHTING ON VARIETIES AND ECOTYPES OF <em>LOLIUM</em>, <em>DACTYLIS</em> AND <em>FESTUCA</em>.
- Published in:
- Journal of Applied Ecology, 1982, v. 19, n. 3, p. 881
- By:
- Publication type:
- Article
PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS).
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3212, doi. 10.3390/jcm9103212
- By:
- Publication type:
- Article
Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01916-2
- By:
- Publication type:
- Article
Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01666-7
- By:
- Publication type:
- Article
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
- Published in:
- Diabetologia, 2021, v. 64, n. 10, p. 2147, doi. 10.1007/s00125-021-05512-5
- By:
- Publication type:
- Article
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.
- Published in:
- Diabetologia, 2021, v. 64, n. 9, p. 1982, doi. 10.1007/s00125-021-05490-8
- By:
- Publication type:
- Article
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease.
- Published in:
- Diabetologia, 2019, v. 62, n. 7, p. 1154, doi. 10.1007/s00125-019-4859-4
- By:
- Publication type:
- Article
Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/487816
- By:
- Publication type:
- Article
Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 4060, doi. 10.1111/dom.15761
- By:
- Publication type:
- Article
Derivation and independent validation of kidneyintelX.dkd: A prognostic test for the assessment of diabetic kidney disease progression.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3779, doi. 10.1111/dom.15273
- By:
- Publication type:
- Article
Mechanisms of action of the sodium‐glucose cotransporter‐2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1950, doi. 10.1111/dom.14779
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor-δ Genotype Influences Metabolic Phenotype and May Influence Lipid Response to Statin Therapy in Humans: A Genetics of Diabetes Audit and Research Tayside Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 4, p. 1830, doi. 10.1210/jc.2009-1201
- By:
- Publication type:
- Article
A Single Nucleotide Polymorphism on Exon-4 of the Gene Encoding PPARδ Is Associated with Reduced Height in Adults and Children.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 7, p. 2587, doi. 10.1210/jc.2009-0392
- By:
- Publication type:
- Article
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 9, p. 3247, doi. 10.3390/jcm12093247
- By:
- Publication type:
- Article
Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1350796
- By:
- Publication type:
- Article
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01558-w
- By:
- Publication type:
- Article
Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: a retrospective cohort study.
- Published in:
- BMC Endocrine Disorders, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12902-019-0417-9
- By:
- Publication type:
- Article
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet-Fed Mice and Improved by Rosiglitazone.
- Published in:
- Diabetes, 2007, v. 56, n. 7, p. 1751, doi. 10.2337/db06-1135
- By:
- Publication type:
- Article
Selective CETP Inhibition and PPARα Agonism Increase HDL Cholesterol and Reduce LDL Cholesterol in Human ApoB100/Human CETP Transgenic Mice.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2010, v. 15, n. 2, p. 196, doi. 10.1177/1074248410362891
- By:
- Publication type:
- Article
Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lifetime benefits of early detection and treatment of diabetic kidney disease.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217487
- By:
- Publication type:
- Article
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sciatic inflammatory neuritis (SIN): Behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production.
- Published in:
- Journal of the Peripheral Nervous System, 2001, v. 6, n. 3, p. 111, doi. 10.1046/j.1529-8027.2001.006001111.x
- By:
- Publication type:
- Article
Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182932
- By:
- Publication type:
- Article
Role of Glycosuria in SGLT2 Inhibitor–Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial.
- Published in:
- Diabetes, 2024, v. 73, n. 2, p. 250, doi. 10.2337/db23-0448
- By:
- Publication type:
- Article
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
185-OR: Longitudinal Changes in KidneyIntelX and Association with Progressive Decline in Kidney Function in the CANVAS Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-185-OR
- By:
- Publication type:
- Article
139-LB: The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-139-LB
- By:
- Publication type:
- Article
1123-P: Stress Cardiac Biomarkers and Adverse Cardiac Outcomes in the CANagliflozin CardioVascular Assessment Study (CANVAS).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1123-P
- By:
- Publication type:
- Article
1120-P: Association between the Inflammatory Marker GDF-15 and Kidney Disease Progression: Results from the CANVAS Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1120-P
- By:
- Publication type:
- Article
1118-P: Validation of the PromarkerD Test for Predicting Renal Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1118-P
- By:
- Publication type:
- Article
1098-P: Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1098-P
- By:
- Publication type:
- Article